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Abstract
Background: Health-related quality of life (HRQoL) is a commonly used health outcome. For many acute
conditions (e.g. fractures), retrospective measurement of HRQoL is necessary to establish pre-morbid health status.
However, the validity of retrospective measurement of HRQoL following an intervening significant health event has
not been established. The aim of this study was to test the validity of retrospective measurement (recall) of HRQoL
by using a test-retest design to measure reliability and agreement between prospective and retrospective patient-
reported HRQoL before and after an intervening health event (elective orthopaedic surgery).
Method: Participants were recruited from the pre-admission clinic of a metropolitan hospital. Participants were
assessed for their HRQoL using the EQ-5D-5L at two time-points; prospectively at 2 weeks prior to their date of
surgery and then retrospectively (recalling their pre-operative health) following elective hip or knee joint
replacement surgery. Prospective measurements were compared with retrospective measurements for the five
domain scores (nominal data) using intra-class correlation and for the EQ-Index score and EQ-Visual Analogue Scale
(VAS) score (continuous data), using Pearson’s correlation. Agreement was tested in continuous variables using Lin’s
coefficient of concordance (pc) and Bland-Altman plots.
Results: One hundred seventy-four patients consented to participate. Eighty-eight paired prospective and
retrospective scores were collected and there was a median between-test period of 15 days. At a group level, the
prospective measurements were similar to the retrospective measurements; the modes and means of the five
domain scores were not different and the mean differences (MD) between the scores for EQ-Index (MD = 0.02, on a
scale of 0–1) and EQ-VAS (MD = 0.53, on a scale of 1–100) were negligible. However, the correlation of paired scores
was varied; the range of domain score correlations was 0.52 to 0.74, the concordance was substantial for the EQ-
Index scores (pc = 0.76, 95% CI = 0.66, 0.84) and moderate for the EQ-VAS scores (pc = 0.46, 95% CI = 0.28, 0.61).
Conclusion: Agreement between prospective and retrospective measurements was high at a group level and
moderate to substantial at an individual level. Retrospective measurement of HRQoL using the EQ-5D-5L in an
orthopaedic clinical context is a valid alternative to using reference data to estimate baseline or pre-morbid health
status.
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Background
Health related quality of life (HRQoL) is an assessment
and expression of subjective well-being that includes
emotional, social and physical aspects. HRQoL can be
used for health economic purposes and as an outcome
measure in the treatment of health conditions. HRQoL
is measured at an individual level; it is not directly ob-
servable and is only deducible from patients’ responses
to questionnaires [1].
The EuroQol instruments are non-disease specific ex-
amples of multi-dimensional tools to measure HRQoL
and the most widely applied version is the EQ-5D [2]
with the five-level version (EQ-5D-5L) the most recent
version. The EQ-5D-5L produces both categorical (five
dimensions) and continuous data (utility index score and
visual analogue scale, VAS, score). The five descriptive
dimensions are combined according to a scoring algo-
rithm to produce a quantitative index score (EQ-index)
that can be compared to normative values. The index
scores range from 1 (full health) to 0 (equivalent to
death), with scores less than 0 defined as health states
worse than death. Population norms for EQ-index scores
have been reported for various populations around the
world but none are available for Australia [2]. The EQ-
5D VAS can be used as an outcome in itself or to help
weight the index scores.
The EQ-5D is commonly used and has been widely
compared with other instruments and validated in mus-
culoskeletal health-specific contexts. A recent systematic
review demonstrated good reliability and validity and
moderate responsiveness [3]. Two studies using cohorts
of patients being treated for carpal tunnel syndrome
found excellent reliability [4], strong validity and min-
imal bias for age and gender [5]. The properties of the
EQ-5D have also been tested in musculoskeletal health-
specific contexts such as proximal humeral fractures [6],
adolescent idiopathic scoliosis [7], rheumatoid arthritis
[8–10], lower back surgery [11] and knee osteoarthritis
[12, 13] with similar outcomes reported.
The EQ-5D is only recommended for prospective use.
The EuroQol instruments are framed in the present
tense and there are no retrospective versions available.
In a clinical context, unless the health condition is fore-
seeable, the clinician or health researcher does not have
a baseline measure of the patient’s pre-morbid health
state. Normative population-level, non-disease specific
data can be used, or retrospective measurement of base-
line health status can be measured. However, this is sus-
ceptible to recall bias. In a health economics context, the
retrospective assessment of health status, gathered for
the purpose of estimating healthy life expectancy has
been shown to closely approximate estimates based on
prospective health information [14]. Numerous studies
have investigated the test-retest reliability of the EQ-5D
[15–20] and other studies have supported the use of
retrospective measurement of baseline data following a
health event or an intervention [21–23], and retrospect-
ive measurement in preference to using population
norms in determining baseline health status [24, 25].
However, the validity of the retrospective use of the EQ-
5D has not been established.
The primary aim of this study was to use a significant
health event, elective hip or knee joint replacement sur-
gery, to determine the validity of the retrospective meas-
urement of self-reported health status using the EQ-5D-
5L, comparing it to prospective measurement.
Methods
Recruitment and data collection
This study was designed as a test-retest reliability study
with the test being the prospective (contemporaneous)
measure of pre-operative health and the retest being the
retrospective (recalled) measure of pre-operative health
using EQ-5D, recorded after a major intervening health
event. The tests were conducted 2 weeks apart and with
elective hip or knee joint replacement surgery occurring
in between. The study was conducted at The Sutherland
Hospital, Sydney, Australia. Ethics approval was granted
by the hospital ethics committee (LNR/17/POWH/384)
and permission was granted by EuroQoL for the use of
the EQ-5D-5L in this study.
Patients were screened through the elective surgery
waitlist and recruited in-person from the pre-admission
clinic. Patients were eligible for inclusion if they were (a)
aged 18 years and older, and (b) presented for an elective
hip or knee arthroplasty (e.g. total hip replacement or,
knee replacement including bilateral and unicompart-
mental knee replacement). Patients were excluded if they
were (a) unable to consent because they were cognitively
impaired or not proficient in English, (b) unable to be
contacted by telephone because they were hearing im-
paired or did not own a phone, or (c) unsuitable to be
assessed prospectively because their planned date of op-
eration was within 10 days of presentation or they
planned on being overseas during the prospective period.
At recruitment, participants were shown the format of
the EQ-5D-5L and were given a hardcopy as part of the
patient information consent form, so that they were fa-
miliar with the question format for telephone interview
due to occur 2 weeks prior to planned surgery.
Participant data were collected relating to identifying
information (name, date of birth, sex and medical record
number), contact details (primary and secondary phone
numbers), eligibility status, participation status (con-
sented, declined or missed), primary language, operation
type, important dates (pre-admission clinic, planned op-
eration and actual operation), and the prospective and
retrospective EQ-5D-5L (date of administration and
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scores). The prospective measurement was conducted by
telephone 2 weeks pre-operatively by an investigator
(AT). Participants completed the unmodified EQ-5D-5L
by telephone with respect to their current, pre-operative
health status.
The retrospective measure was administered verbally,
in-person at the hospital post-operatively (AL, AP and
MK), prior to their discharge from hospital. Participants
were asked to recall their pre-treatment health status as
it was 2 weeks prior to their surgery using a modified
EQ-5D-5L (past tense) questionnaire administered
verbally.
Statistical analysis
A sample size of 77 was determined using Zou’s (2012)
sample size calculation incorporating assurance prob-
ability [26]. A sample size of 77 ensured a 90% assurance
probability given the half width of a 95% two-sided con-
fidence interval for a correlation or concordance of 0.8.
The retrospective EQ-5D-5L measurements were com-
pared with prospective measurements; the EQ-5D-5L
produces seven separate outcomes (5 domain scores, an
index score and a VAS score) and each prospective out-
come was paired with its retrospective outcome and
tested for correlation. The five domain scores were
assessed for intra-class correlation (ICC). The domain
scores were then converted to an index score using a
scoring algorithm estimated from a sample of the United
Kingdom (UK) adult general population, using an EQ-
5D-5L calculator. The calculator was developed by Shef-
field Hallam University on behalf of The Chartered Soci-
ety of Physiotherapy (United Kingdom) in 2011 [27].
The purpose of the tool is to enable illustration of
change in quality of life as a result of physiotherapy in-
terventions. However, in this instance, we used the tool
to pair prospective and retrospective HRQoL scores and
to display the distribution of difference in domains
scores. The prospective index scores and VAS scores
were correlated with the retrospective scores. Agreement
was assessed for the continuous variables (EQ-index and
EQ-VAS scores). Bland-Altman plots were made with
95% limits of agreement (LOA) and Lin’s concordance
correlation coefficient (pc) was calculated. To interpret
the results for correlation and for agreement, we used
benchmarks defined by Cicchetti (1994), whereby 0.21 to
0.4 represented ‘fair’, 0.41–0.60 was ‘moderate’, 0.61–




Three hundred fifty-five patients attended the pre-
admission clinic for joint replacement surgery at our fa-
cility in the period from 27 September 2017 to 28
September 2018 and 291 patients were screened for eli-
gibility, of which 78 were ineligible, 39 declined to par-
ticipate and 174 consented to participate. Prospective
outcomes were gathered on 144 participants and retro-
spective outcomes were gathered on 104 participants.
Both prospective and retrospective outcomes were gath-
ered for 88 participants. The median time between tests
was 15 days, the range was 3 to 64 days and the mean
follow-up was 19 days.
The main reason for missing prospective measure-
ments on recruited participants at the pre-operative
stage was that the participant could not be contacted by
their primary or secondary telephone number after five
attempts on consecutive weekdays. The main reason for
missing retrospective measurements on post-operative
participants was that the patient’s date of surgery was
changed or cancelled after their attendance at pre-
admission clinic. Other reasons included that the patient
required an escalation in their medical treatment after
surgery (e.g. critical care admission) or they were dis-
charged from the hospital before their follow-up. Partici-
pant flow is shown in Fig. 1.
The demographic characteristics of the study sample
are described in Table 1. The mean age of participants
was similar to non-participants. There were slightly
more female participants (51%) than male participants
and there were more knee replacements (67%) than hip
replacements (33%) in this sample. English was the pre-
dominant first language for both participants and non-
participants but, given that English-proficiency was an
inclusion criterion for participation, the proportion of
first languages other than English was higher in the
population (26%) than in the study sample (8%).
Categorical variables
Comparisons of the nominal data are displayed in
Table 2. The medians and the modes for each of the five
dimensions remained unchanged between the prospect-
ive and the retrospective measurements, indicating negli-
gible difference between prospective and retrospective
measurements at a group level.
The distribution of difference from prospective to
retrospective measurements in each of the five dimen-
sions is illustrated in Appendix 1. The distribution of
change provides an indication of the magnitude and dir-
ection of difference in scores in each dimension from
prospective to retrospective measurements. The range of
agreement in paired prospective and retrospective scores
was 48% (usual activities) to 65% (mobility).
The results gathered from each of the five EQ dimen-
sions are presented in 5 × 5 tables (Appendix 2). Intra-
class correlation coefficient (ICC) scores were reported
for each of the five domains. Correlation was moderate
for usual activities (r = 0.52) and anxiety/depression (r =
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0.54) and was substantial for mobility (r = 0.74), personal
care (r = 0.62) and pain/discomfort (r = 0.65).
Continuous variables
The mean differences (MDs) for each of the continuous
variables were negligible; 0.53 on a scale of 0 to 100 for the
EQ-VAS and 0.02 on a scale of 0 to 1 for the EQ-Index.
This indicated strong agreement between prospective and
retrospective measures at a group level. However, the
Bland-Altman plots and Lin’s concordance (pc) for paired
EQ-VAS and EQ-Index scores indicated that agreement at
an individual level was lower. The Bland-Altman plots for
EQ-VAS (Fig. 2) and EQ-Index (Fig. 3) scores show that
the 95% LOA. around the MD were − 32.34 to 33.38, on a
scale of 0–100 for the EQ-VAS and − 0.31 to 0.36 on a
scale of 0–1 for the EQ-Index. Agreement was moderate
Fig. 1 Participant flow diagram







Age (years) Mean (range) 68 (32–88) 68 (26–91)
Sex Male 43 (49%) (unknown)
Female 45 (51%) (unknown)
First Language English 81 (92%) 203 (74%)
Other than English 7 (8%) 73 (26%)
Procedure Hip replacement 29 (33%) (unknown)
Knee replacement 59 (67%) (unknown)
Dates Median (range) duration between prospective
and retrospective dates (days)
15 (3 to 64)
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for EQ-VAS (pc = 0.46 95% CI, 0.28, 0.61) and substantial
for EQ-Index scores (pc = 0.76 95% CI, 0.66, 0.84) (Table 3).
Discussion
The results of this study showed that retrospective
measurement of HRQoL produced equivalent results to
prospective measurement at a group level but agreement
was lower at an individual level. We could find no dir-
ectly comparable studies but numerous recent studies
investigating test-retest reliability of the EQ-5D-5L tool
(not using recall of health status) have reported similar
differences between the two testing periods (Table 4). A
2018 study surveyed a cross-section of the Indonesian
general adult population [15] with a mean between-test
period of 17 days. The findings were similar to our find-
ings in that the group-level correlations were high for
the five dimensions (ICC = 0.85–0.99) but that agree-
ment for the EQ-VAS and EQ-Index scores was much
lower (pc = 0.45 and 0.37 respectively). An English study
examined the test-retest reliability of the EQ-5D-3L in
the UK general population and reported an ICC of 0.83
in the EQ-Index scores [16]. A Chinese study of carers
of cancer patients reported high test-retest reliability for
EQ-VAS and EQ-Index scores of 0.87 and 0.99 respect-
ively [17]. However, the follow-up between test and re-
test in that particular study was only 1 day meaning the
results were likely to be heavily influenced by recall bias
compared with the results of our study. Other studies
with similar follow-up periods to our study have re-
ported test-retest ICCs for EQ-Index scores of 0.78 [18],
0.70 [19] and 0.75 [20]. These results would lead us to
suggest that retrospective measurement of baseline
health status produces similar test-retest reliability com-
pared to studies measuring current (prospective) health
status at a similar interval.
Similar findings have been reported in the context of
testing the validity of different modes of administration
of patient-reported measures. In a 2017 study, the
equivalence of patient-completed and telephone inter-
view modes of administration of the EQ-5D-5L were
Table 2 Descriptive statistics for prospective and retrospective measures
Variable Domain EQ-5D-5L Index EQ-VAS
Mobility Self-Care Usual Activities Pain/ Discomfort Anxiety/ Depression
Prospective (n = 88)
Mean 0.4691 66.89
Median (range) 3.0 (1 to 4) 2.0 (1 to 4) 3.0 (1 to 5) 3.0 (1 to 5) 2.0 (1 to 5) 0.5135 (−0.1994 to 1) 70 (10 to 100)
Mode 3 1 3 3 1
Retrospective (n = 88)
Mean 0.4470 66.36
Median (range) 3.0 (1 to 5) 2.0 (1 to 4) 3.0 (1 to 5) 3.0 (2 to 5) 2.0 (1 to 5) 0.5197 (−0.1464 to 0.8366) 70 (5 to 95)
Mode 3 1 3 3 1
Fig. 2 Bland-Altman plot for EQ-VAS scores
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tested in a cohort of orthopaedic patients [29]. The
equivalence was established according to the minimum
important difference for the index and VAS scales but
correlation between paired domain scores were similar
to or lower than those reported in our study. Another
study from 2014 tested the correlation of mail and tele-
phone administration of the Oxford hip and knee scores
in an orthopaedic cohort [30], showing that the two dif-
ferent modes of administration produced equivalent re-
sults at a group level but that agreement was low at an
individual level.
Bias
Both prospective and retrospective measurements of dif-
ference in self-reported health status are susceptible to
bias. Prospective measurements are subject to scale re-
calibration, a changed conceptualisation of the answer
scale secondary to changed internal standards of con-
struct interpretation and judgement from pre-test to
post-test [1]. Significant intervening health events can
exaggerate this bias by shifting the frame of reference
and catalysing a revaluation of prior and present health
status [31]. In the case of this study, the retrospective
measurement might have been biased by factors such as
general anaesthesia, the trauma of surgery or post-
operative levels of pain. Schwartz & Sprangers (1999)
suggest that this scale recalibration makes the retro-
spective measurement of change in self-reported health
status more appropriate than the prospective measure-
ment of change in self-reported health status because
both recalled and current health status are evaluated
using a consistent internal standard of construct inter-
pretation and judgment [32].
Alternatively, retrospective measurement may be
subject to recall bias, the incorrect self-assessment of
former health status due to inaccurate or incomplete
recollection [1]. Recall bias occurs because recollec-
tion is a reconstructive and inferential process that is
subject to errors, losses, distortions and psychological
processes in the present state and over time [1]. Bias
results in underestimations or overestimations of
former health status which may be non-directional,
occurring by chance and cancelling out on average, or
directional, consistently occurring and producing a
unidirectional error. In this study, recall might have
been biased by general anaesthesia, the trauma of sur-
gery or the side effects of analgesia. To reduce the
chance of recall bias, retrospective measures were
taken as close to the patients discharge from hospital
as possible. Given that our results were very similar
to other test-retest studies that didn’t involve an
intervening health event and that had similar time
Fig. 3 Bland-Altman plot for EQ-Index scores
Table 3 Correlation and agreement for continuous variables
n = 88 EQ-VAS EQ-index
Mean difference (LOA) 0.53 (−32.34, 33.38) 0.02 (− 0.31, 0.36)
Pearson CC (r [p]) 0.46 (p < 0.0001) 0.76 (p < 0.0001)
Lin’s CCC (pc [95% CI]) 0.46 (0.28, 0.61) 0.76 (0.66, 0.84)
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between test and retest, it is unlikely that our results
were affected significantly by scale recalibration or re-
call bias. That said, though not the aim of the study,
the use of a control group that was not exposed to
an intervening health event would have provided evi-
dence either way about the presence of such bias.
Strengths and limitations
The aim of this study was to investigate the validity of
the retrospective use of HRQoL. Many validation studies
test for reliability using correlation but do not necessar-
ily test for agreement using concordance and this can be
problematic in the context of longitudinal studies [33].
Correlation measures the strength of the linear relation-
ship between two measures but does not measure the
equality between paired sets of values. This study used
Bland-Altman plots and assessment of concordance to
investigate agreement between prospective and retro-
spective measures.
The main limitation of this study was the low follow-
up rate of participants. The investigators made efforts to
maximise the follow-up rate by excluding patients who
were less likely to be contactable by phone and by track-
ing patient journeys in the electronic medical record.
The first EQ-5D-5L questionnaire was administered via
telephone and the second EQ-5D-5L questionnaire was
administered face-to-face which increased the risk of de-
tection bias. The risk of bias was minimised by investiga-
tors using standardised explanations and delivering both
surveys verbally. Another limitation was the lack of a
control group which meant that the risk of scale recali-
bration or recall bias could not be assessed.
Conclusions
The validity of measuring HRQoL retrospectively has
not previously been assessed. Our results indicate that
retrospective measurement of HRQoL, using the EQ-
5D-5L in an elective orthopaedic clinical context
provides results that are almost equivalent to prospective
measurement at a group-level but not at an individual
level. These results are similar to the results of studies
investigating test-retest reliability of EQ-5D-5L, suggest-
ing that the retrospective measurement of HRQoL to es-
timate pre-morbid health status is valid.
Appendix 1
Table 4 studies of test-retest reliability of EQ-5D
Study Language Population Follow-up Reliability
Current study English Elective orthopaedic surgery patients Mean of 19 days CCC of 0.46 for EQ-VAS
CCC of 0.76 for EQ-Index
Purba, 2018 [15] Indonesian General population Mean of 17 days ICC and CCC of 0.45 for EQ-VAS
ICC and CCC of 0.37 for EQ-Index
Al-Janabi, 2015 [16] English UK general ppulation 14 days ICC of 0.83 for EQ-Index
Li, 2019 [17] Chinese Carers of cancer patients 24 h ICC of 0.99 for EQ-Index
ICC of 0.87 for EQ-VAS
Cheung, 2016 [18] Chinese Scoliosis patients Mean of 20 days ICC of 0.78 for EQ-index score
Pattanaphesaj, 2015 [19] Thai Diabetes patients Approx. 3 weeks ICC of 0.70 for EQ-Index
Kim, 2013 [20] Korean General population Mean of 19 days ICC of 0.75 for EQ-index score
1.1 Distribution of difference in EQ-mobility scores
1.2 Distribution of difference in EQ-self-care scores
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Appendix 2
1.3 Distribution of difference in EQ-usual activities scores
1.4 Distribution of difference in EQ-pain/discomfort scores
1.5 Distribution of difference in EQ-anxiety/depression scores
2.1 Reliability of Mobility question
Retrospective
1 2 3 4 5
Prospective 1 3 0 1 0 0 4
2 1 9 8 0 0 18
3 0 3 24 11 0 38
4 0 0 6 21 1 28
5 0 0 0 0 0 0
4 12 39 32 1 88
ICC = 0.74
2.2 Reliability of Personal Care question
Retrospective Totals
1 2 3 4 5
Prospective 1 27 10 5 0 0 42
2 2 8 6 2 0 18
3 3 5 11 3 0 22
4 0 1 2 3 0 6
5 0 0 0 0 0 0
Totals 32 24 24 8 0 88
ICC = 0.62
2.4 Reliability of Pain/Discomfort question
Retrospective Totals
1 2 3 4 5
Prospective 1 0 3 1 0 0 4
2 0 5 6 0 0 11
3 0 8 18 12 0 38
4 0 0 11 17 1 29
5 0 0 0 2 4 6
Totals 0 16 36 31 5 88
ICC = 0.65
2.3 Reliability of Usual Activities question
Retrospective Totals
1 2 3 4 5
Prospective 1 4 2 3 0 0 9
2 1 8 5 2 0 16
3 3 9 22 6 2 42
4 1 0 7 7 2 17
5 0 0 0 3 1 4
Totals 9 19 37 18 5 88
ICC = 0.52
2.5 Reliability of Anxiety/Depression question
Retrospective Totals
1 2 3 4 5
Prospective 1 29 7 5 0 0 41
2 3 9 4 1 0 17
3 4 8 7 3 1 23
4 1 0 2 2 0 5
5 0 0 2 0 0 2
Totals 37 24 20 6 1 88
ICC = 0.54
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